
Making clinical decisions clearer,
one result at a time
Lighthouse Labs is a CLIA-certified molecular pathology laboratory in Jacksonville, Florida — built around rapid multiplex PCR testing, reviewed by board-certified pathologists, and reported in 24–48 hours.





— What Sets Us Apart
A laboratory built around
the clinician's next decision
Every assay we run, every report we send, is engineered to do one thing: give the ordering provider the answer they need, the moment they need it. Our pathologists, scientists, and account managers operate as a single extension of your practice.
— The Lighthouse Difference
Come experience the
Lighthouse difference
Trained in both molecular methodology and clinical workflow, our laboratory team specializes in infectious disease PCR, antibiotic resistance profiling, toxicology, and women's health — with special depth in complicated UTI, recurrent vaginosis, and wound care.
Each result is reviewed by a board-certified molecular pathologist before it leaves our lab, and every provider has direct access to our scientific team for case consultation. We don't send back data — we send back a decision.


— 01 / 04
PCR Diagnostics
Multiplex real-time qPCR panels run on the Bio-Rad CFX384 platform — pathogen-level resolution that culture alone cannot offer.

— 02 / 04
UTI Panel
A 10-target urinary panel covering the most common uropathogenic bacteria and Candida species, with reflex to the 8-gene ABR panel on bacterial positives.

— 03 / 04
Respiratory Panel
5-target respiratory panel — SARS-CoV-2, Influenza A, Influenza B, and RSV A/B — reported in 24–48 hours for time-critical decisions.

— 04 / 04
Antibiotic Resistance
8 resistance gene markers — mecA/C, VanA, VanB, KPC, NDM, CTX-M, Sul1/2, and DfrA — reflexed from positive UTI and Wound bacterial targets to guide narrow-spectrum therapy.
— Partner With Us
Let us help your patients
get the answers they need
Onboard your practice in days, not weeks. Couriers, supplies, EMR integration, and a real human account manager — all included.
